Institute for Wealth Management’s Myriad Genetics MYGN Stock Holding History

Institute for Wealth Management’s Portfolio MYGN Stock Details MYGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.2K	Buy	+561	New	+$2.55K	﹤0.01%	1523

Other funds holding MYGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return

OAM

OP Asset Management Helsinki $9.38B AUM 42.35% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

PAM

Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Institute for Wealth Management's MYGN Position: Q2 2026 in Review

Institute for Wealth Management opened a new position in Myriad Genetics (MYGN) in Q2 2026: 561 shares worth $3.2K. The stake represents ﹤0.01% of the portfolio and ranks #1523 among its holdings.

64 funds tracked by Wall St. Rank hold MYGN as of Q2 2026.

Institute for Wealth Management held 561 shares of Myriad Genetics worth $3.2K as of Q2 2026.
Myriad Genetics was a new Institute for Wealth Management position in Q2 2026.
Myriad Genetics made up ﹤0.01% of Institute for Wealth Management's portfolio in Q2 2026, its #1523 holding.
64 funds tracked by Wall St. Rank held Myriad Genetics as of Q2 2026.

Based on Institute for Wealth Management's 13F filing for Q2 2026, filed 28 Jul 2026.